Examining the prevalence of prediabetes in pediatrics (VIDEO)
For Contemporary Pediatrics, Dr Bobby Lazarra discusses a survey study published in JAMA Pediatrics that looks at the prevalence of prediabetes in the pediatric population of the United States.
For Contemporary Pediatrics, Dr Bobby Lazarra discusses a survey study published in JAMA Pediatrics that looks at the prevalence of prediabetes in the pediatric population of the United States.
Crinecerfont safe, effective in treating children with congenital adrenal hyperplasia
October 10th 2023Crinecerfont, an investigational, oral, selective corticotropin-releasing factory type 1 receptor antagonist, achieved the primary and key secondary endpoints in a phase 3 study to treat congenital adrenal hyperplasia due to 21-hydroxylase deficiency in children aged 2 to 17 years.
FDA approves teplizumab for delay of type 1 diabetes in patients 8 years and up
November 18th 2022The US FDA announced the approval of teplizumab (Tzield), which is administered through IV infusion once daily for 14 consecutive days, for delaying the onset of stage 3 type 1 diabetes in adults and pediatric patients 8 years and older who currently have stage 2 type 1 diabetes.
Study finds children, young adults with down syndrome more likely to develop diabetes
October 17th 2022An analysis of data from more than 9900 people with Down syndrome and 38,000 controls provides new insight into the apparent increase in risk of developing diabetes among children and young adults with Down syndrome.
In gestational diabetes, tighter glycemic targets could influence outcomes for mother and child
September 23rd 2022Results of the TARGET trial provide insight into the effects of tight glycemic targets versus less tight targets on maternal and perinatal outcomes among women with gestational diabetes.
